摘要
目的:探讨经皮肾镜辅助小切口取石术在合并糖尿病、高血压病及再次手术结石患者中的临床应用价值。方法:观察组20例采用经皮肾镜辅助小切口取石术式,手术切口长5~7cm,肾脏穿刺通道用2—0可吸收缝合线全层缝合,不留置肾造瘘管,肾周不留置血浆引流管。对照组21例采用经皮肾镜取石术式,留置F18~50肾造瘘管。两组患者均使用瑞士EMS-Vario混合动力碎石清石系统进行手术。结果:两组中合并糖尿病、高血压病及再次手术患者人数比较,差异无统计学意义。观察组患者无大出血、气胸、邻近脏器损伤等严重并发症,伤口均甲、乙级愈合,随访3个月无继发性肾出血。对照组继发性肾出血4例,发生率19.05%,经超选择性肾动脉介入栓塞治疗后痊愈出院。结论:经皮肾镜辅助小切口取石术能有效降低合并糖尿病、高血压病及再次手术患者继发性肾出血的发生率,有实际临床应用价值。
Objective:To explore the clinical application value of small-incision assisted percutaneous nephros- tolithotomy(PCNL) among patients who suffer from diabetes mellitus, hypertension and re-operation. Methods: The small-incision assisted PCNL was used in experimental group (20 cases), which the operative incision was 5- 7 cm long, sewed up by 2-0 absorbable suture. Nephrostomy tube and blood plasma tube were not reserved. Meanwhile the PCNI. was used in control group (21 cases), which the NO. F18-20 nephrostomy tube was reserved. However the Swiss Litho Clast Msater VARIO was used in two groups. Results:The difference of the cases of the patients who suffered from diabetes mellitus, hypertension and re-operation between two groups was not statisti- cally significant (P〈0.05). No hemorrhea, pneumothorax, injury of peripheral organs and other serious compli- cation occurred in experimental group. The incision healed on the first or second level, and the related nephrorrha- gia did not occur after 3 months. However, there were 4 cases occurring related nephrorrhagia in control group (incidence rate was 19.05 %) who were healed by super selective renal artery embolization. The difference of the related nephrorrhagia between the two groups was statistically significant (P〈0. 05). Conclusions:The small-inci- sion assisted PCNL can effectually reduce the incidence rate of the related nephrorrhagia among the patients who suffered from diabetes mellitus, hypertension and re-operation. The value of clinical application is obvious.
出处
《临床泌尿外科杂志》
2013年第8期575-577,共3页
Journal of Clinical Urology
关键词
经皮肾镜取石术
辅助小切口
高危结石患者
percutaneous nephrolithotomy, small-incision assisted
high risk calculus patients